ESSEX INVESTMENT MANAGEMENT CO LLC
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 201772
BOSTON, MA
Position in AGIO
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$3,490,477
New position
Shares Held
103,177
first reported quarter
Ownership
0.173%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 50%
Shared 0%
None 50%
Position in Biotechnology
Healthcare · as of Mar 31, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $60,210,603 across 12 Biotechnology names. AGIO ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
58,460 | $11,671,539 | |
| 2 | INSM |
INSMED Inc
|
62,676 | $10,248,779 | |
| 3 | MIRM |
Mirum Pharmaceuticals, Inc.
|
108,338 | $10,008,264 | |
| 4 | TVTX |
Travere Therapeutics, Inc.
|
161,705 | $4,804,255 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
198,985 | $4,648,289 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
21,778 | $4,117,130 | |
| 7 | AGIO |
Agios Pharmaceuticals, Inc.
This page
|
103,177 | $3,490,477 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
143,934 | $3,391,085 |
All Filings in AGIO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,490,477 | 103,177 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||